While the gold standard smoking-cessation drug, Pfizer’s Chantix, once grossed over $1 billion a year, that’s no longer enough to excite drugmakers, who have become accustomed to bringing in ...

Learn how quitting smoking can dramatically reduce your cancer risk over time Find out the benefits of complete cessation ...

Throughout so many trying situations over the past 25 years, Quitline services have remained reliable and ready.

Cigarette smoking declines over the past several decades prevented an estimated 3.8 million lung cancer deaths, according to results of a retrospective study.Smoking cessation and reduction also ...

Tobacco use is a modifiable risk factor attributed to an increased risk for many cancers, including esophageal cancer. What has research shown about the specific ways smoking affects esophageal risk ...

Smoking cessation within 6 months of a cancer diagnosis can significantly improve survival, according to results of a prospective study.Individuals who quit smoking during that time survived ...

Similarly, smoking cessation is expected to contribute to the improvement of endothelial dysfunction, although the existing evidence to substantiate its positive effects is limited.

Study: Efficacy of e-health interventions for smoking cessation management in smokers: a systematic review and meta-analysis. Image Credit: a-image/Shutterstock.com Background Smoking cessation is ...

Six- or 12-week cytisinicline schedules supplemented with behavioral support demonstrated smoking cessation efficacy in clinical trial participants, offering new nicotine dependence treatment options.

In addition to a slight and temporary risk for blood sugar imbalance, smoking cessation is associated with reduced risks for all-cause mortality and for macro- and microangiopathic complications.

Source Reference: Tran DT, et al "Risk of major congenital malformations following prenatal exposure to smoking cessation medicines" JAMA Intern Med 2025; DOI: 10.1001/jamainternmed.2025.0290.

Study Design: A descriptive case series review was undertaken of smoking cessation service patients in the short-stay unit of an acute hospital in Singapore from July 1, 2018, to December 31, 2019.